Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.
We sought to determine whether oral fluid can be used to assess serum human papillomavirus (HPV) antibody status by enrolling women who had received a prophylactic HPV-16 vaccine in a new follow-up study. After the prophylactic HPV-6/11/16/18 vaccine was licensed in the United States, we administered it to consenting participants. With serologic findings used as the reference standard, The sensitivity of oral fluid was 49.6% (95% confidence interval [CI], 42.0%-57.3%) before and 100% (95% CI, 92.0%-100%) after administration of the quadrivalent vaccine. Oral fluid may have the potential to be used for monitoring of prophylactic HPV vaccines in the future.
Rowhani-Rahbar
Ali
A
Department of Epidemiology, University of Washington, Seattle, WA 98125, USA. rowhani@u.washington.edu
Carter
Joseph J
JJ
Hawes
Stephen E
SE
Hughes
James P
JP
Weiss
Noel S
NS
Galloway
Denise A
DA
Koutsky
Laura A
LA
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis / Q000276:immunology*; D005122:Exudates and Transudates / Q000276:immunology*; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D052162:Human papillomavirus 16 / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D007074:Immunoglobulin G / Q000032:analysis / Q000276:immunology*; D009061:Mouth Mucosa / Q000276:immunology; D053918:Papillomavirus Vaccines / Q000276:immunology*; D012372:ROC Curve; D016032:Randomized Controlled Trials as Topic
D000914:Antibodies, Viral; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D007074:Immunoglobulin G; D053918:Papillomavirus Vaccines
J Clin Virol. 2006 Apr;35(4):450-3
16316777
J Med Virol. 2007 Sep;79(9):1375-80
17607771
Vaccine. 2007 Jun 21;25(26):4931-9
17499406
Lancet. 2006 Apr 15;367(9518):1247-55
16631880
Vaccine. 2006 Jul 7;24(27-28):5571-83
16753240
Ann N Y Acad Sci. 1993 Sep 20;694:330-1
7692802
Am J Med. 1997 Apr 1;102(4A):21-5
9217635
J Immunol Methods. 2006 Feb 20;309(1-2):200-4
16406059
Obstet Gynecol. 2006 Jan;107(1):18-27
16394035
BMC Infect Dis. 2006 Jun 08;6:95
16762074
Clin Chem. 2005 Oct;51(10):1845-53
16099939
J Clin Virol. 2005 Dec;34 Suppl 1:S22-8
16461219
Clin Diagn Lab Immunol. 2003 May;10(3):431-8
12738644
Bull World Health Organ. 2001;79(7):588-95
11477961
J Med Virol. 2001 Sep;65(1):149-54
11505457